Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-03-16 to 2023-04-06
Current total value of award: $5415.9
Description: 4560347642!XOLAIR 150 MG/ML SYRINGEML